These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20545479)

  • 41. Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: a retrospective cohort study.
    Koo HM; Doh FM; Ko KI; Kim CH; Lee MJ; Oh HJ; Han SH; Kim BS; Yoo TH; Kang SW; Choi KH
    BMC Nephrol; 2013 Jul; 14():146. PubMed ID: 23849485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy.
    Cirit M; Toprak O; Yesil M; Bayata S; Postaci N; Pupim L; Esi E
    Nephron Clin Pract; 2006; 104(1):c20-7. PubMed ID: 16685140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
    Majumdar SR; Kjellstrand CM; Tymchak WJ; Hervas-Malo M; Taylor DA; Teo KK
    Am J Kidney Dis; 2009 Oct; 54(4):602-9. PubMed ID: 19535188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.
    Iakovou I; Dangas G; Mehran R; Lansky AJ; Ashby DT; Fahy M; Mintz GS; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    J Invasive Cardiol; 2003 Jan; 15(1):18-22. PubMed ID: 12499523
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Feasibility study of the RenalGuard™ balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients.
    Dorval JF; Dixon SR; Zelman RB; Davidson CJ; Rudko R; Resnic FS
    Int J Cardiol; 2013 Jun; 166(2):482-6. PubMed ID: 22204847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients.
    Wacker-Gußmann A; Bühren K; Schultheiss C; Braun SL; Page S; Saugel B; Schmid S; Mair S; Schoemig A; Schmid RM; Huber W
    AJR Am J Roentgenol; 2014 Feb; 202(2):452-8. PubMed ID: 24450691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome.
    Lakhal K; Ehrmann S; Chaari A; Laissy JP; Régnier B; Wolff M; Pajot O
    J Crit Care; 2011 Dec; 26(6):593-9. PubMed ID: 21737245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.
    Saritemur M; Turkeli M; Kalkan K; Tanboga İH; Aksakal E
    Am J Emerg Med; 2014 Feb; 32(2):119-23. PubMed ID: 24238488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteinuria as a predictor of renal dysfunction in trauma patients receiving intravenous contrast.
    Clark JJ; Wong LL; Lurie F; Kamitaki BK
    Am Surg; 2011 Sep; 77(9):1194-200. PubMed ID: 21944630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].
    He YT; Tan N; Liu YH; Chen SQ; Liu Y; Huang SJ; Yang DH; Ye P; Ran P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):394-8. PubMed ID: 24021122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mortality associated with nephropathy after radiographic contrast exposure.
    From AM; Bartholmai BJ; Williams AW; Cha SS; McDonald FS
    Mayo Clin Proc; 2008 Oct; 83(10):1095-100. PubMed ID: 18828968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
    Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
    Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.
    Marenzi G; Lauri G; Assanelli E; Campodonico J; De Metrio M; Marana I; Grazi M; Veglia F; Bartorelli AL
    J Am Coll Cardiol; 2004 Nov; 44(9):1780-5. PubMed ID: 15519007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
    Worasuwannarak S; Pornratanarangsi S
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Contrast-induced nephropathy after cardiac catheterization: a prospective study of 180 patients].
    Mghaieth F; Ayari J; Ben Rejeb R; Mbarki S; Farhati A; Larbi N; Boussaada R; Mourali MS; Mechmeche R
    Tunis Med; 2012 Apr; 90(4):320-7. PubMed ID: 22535348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min.
    Nyman U; Almén T; Aspelin P; Hellström M; Kristiansson M; Sterner G
    Acta Radiol; 2005 Dec; 46(8):830-42. PubMed ID: 16392608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.
    Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography.
    Lee JH; Chung B; Lee SC; Kim SS; Koh HJ; Lee CS
    BMC Ophthalmol; 2017 Apr; 17(1):46. PubMed ID: 28420348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
    Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R
    Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.